SUMMARY Osteoarticular amyloidosis occurred in a patient receiving long term haemodialysis. Histological examination showed that the amyloid deposit was surrounded by inflammatory cells and macrophages filled with haemosiderin. Electron microscopy showed that the amyloid fibrils were in close contact with cytoplasmic expansions, or located in intracytoplasmic pockets of the infiltrating cells. Immunohistological and immunoultrastructural observations confirmed that f2-microglobulin was a major constituent of amyloidosis associated with dialysis. Amyloid P component was also detected within the amyloid deposits.
The factors leading to 2-microglobulin deposition and amyloid formation in this new form of amyloidosis remain to be determined. In particular, the mechanisms responsible for the preferential accumulation of ,B2-microglobulin-derived amyloid in the synovia are still unknown, and the possible adjuvant role of other proteins or inflammatory cells has to be considered.
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In this paper we report a case of amyloidosis associated with dialysis in which the cellular environment of the deposits as well as their chemical composition were studied both at histological and ultrastructural levels.
Case report
A 53 year old woman with end stage renal failure secondary to polycystic kidney disease had been receiving haemodialysis for 15 years with cuprophane membranes. She had severe secondary hyperparathyroidism, which required subtotal parathyroidectomy and also aluminium osteomalacia which was treated by deferrioxamine. From 1984 onwards she developed a destructive spondylarthropathy affecting the lumbar spine, a right carpal tunnel syndrome, and a lytic lesion of the right femoral head.
She was admitted for prosthetic replacement of the right hip. At operation severe hypertrophy of the synovial tissues was noted, and the femoral head displayed a depressed area on the lateral side of the articular surface.
After surgery tissue blocks were fixed in Bouin's fixative, embedded in paraffin, and routinely processed for optical observation. Sections stained with Congo red before and after potassium permanganate "treatment"'2 were examined by conventional and polarised light microscopy.
Immunohistochemical studies were carried out Osteoarticular amyloidosis associated with haemodialysis using a rabbit peroxidase-antiperoxidase method'3 after incubation with anti-human K or A light chain (Becton Dickinson), anti-human P2-microglobulin (Dakopatts), anti-human amyloid P component (Dakopatts), and anti-human amyloid AA (Behring Diagnostics) monospecific antibodies. All the primary antisera were diluted 1/1000. Small pieces oftissue were immersed in 4% glutaraldehyde, treated with osmium tetroxide, and embedded via propylene oxide into epon. Ultrathin sections were cut and observed with a Philips 400T electron microscope after staining with uranyl acetate and lead citrate.
The immunogold technique was performed as previously described'4 with minor modifications: tissues were fixed for two hours in 4% paraformaldehyde and 0I1% glutaraldehyde in phosphate buffer, washed overnight in buffer, dehydrated, and embedded in LR white resin (TAAB Laboratories, England). Sections (50 nm) mounted on nickel grids were etched with 10% distilled water for 10 minutes, incubated with normal goat serum (diluted 1/10) for 30 minutes, and then with anti-#2-microglobulin or anti-amyloid P component antibodies (diluted 1/1000) for 24 hours. After washing in 0-02 M Tris buffered saline (pH 8.2) containing 01 % bovine serum albumin, grids were incubated for one hour with gold labelled goat antirabbit immunoglobulin antibodies, diluted 1/20 (Janssens Pharmaceuticals, Belgium). The size of the gold particles was 10 nm.
Results
The cystic lesion of the femoral head was filled with brown haemorrhagic friable material, surrounded by medullary bone. Hematoxylin and eosin stained slides showed granulation tissue separated by thin strands of fibrosis. The granular, amorphous deposits were surrounded by numerous giant cells, macrophages filled with haemosiderin, fibroblasts, some lymphocytes and plasma cells (fig la) . Other areas comprised acellular granular material and fibrosis. Deposits of positive substance for Congo red were observed on all tissue sections, and by polarised light microscopy showed green dichroism characteristic of amyloid ( fig  I b )(the Congo red affinity and dichroism were reduced by treatment beforehand of the sections with potassium permanganate). Amyloid was also observed in adjacent hyperplastic synovial tissues, which contained inflammatory cells and numerous macrophages laden with haemosiderin pigments.
Immunoperoxidase methods showed no clear reaction of the amyloid deposits with anti-human amyloid A, anti-human K or ) light chains antibodies. With anti-human P2-microglobulin antibodies, the amyloid deposits gave a distinctly positive reaction (fig lc) . 159 Anti-amyloid P component also gave a positive reaction, and this has located at the same level as anti-fl2-microglobulin (fig ld) . The amyloid substance formed in the bone and in the synovial tissue displayed the same immunohistochemical characteristics.
Electron microscopical examination showed that the amyloid deposits were composed offibres ofabout 8 nm in diameter. In the cellular areas the amyloid fibrils were disposed in aggregates separated by thin collagen bundles. When giant cells, fibroblasts, and inflammatory cells were present the amyloid fibrils were in close contact with cytoplasmic expansions or located in intracytoplasmic pockets (fig 2) . Some cells seemed to be filled with amyloid and mummified.
Ultrastructural phages are thought to be responsible for this process. '9 As in our case, macrophages and multinucleated giant cells were indeed often observed around amyloid Depierreux, Goldman, Fayt, Richard, Quintin, Dhaene, Van Herweghem deposits.2 Our observation of amyloid fibrils within the cytoplasm ofsome ofthese cells would suggest that they actively participate in pathogenesis, either by degrading or by generating 2-microglobulin-derived amyloidosis. Interestingly, haemodialysis has been shown to affect monocyte function and particularly to promote interleukin-l generation.' A possible association between interleukin-1 production and amyloidosis associated with dialysis has already been suggested. 2' Amyloidosis associated with dialysis is mainly observed in patients treated with cuprophane membranes.9 This may be related to the inability of these membranes to clear fi2-microglobulin or to their so called bioincompatibility, resulting in activation of different biological systems including interleukin-1.22 Further studies are required to clarify the mechanisms responsible for this new type of amyloidosis to define new strategies which would prevent this major complication of long term haemodialysis.
